Baxter International Inc. (FRA:BTL)
Germany flag Germany · Delayed Price · Currency is EUR
25.97
+0.02 (0.10%)
At close: Jul 8, 2025, 10:00 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Chronic Therapies
-
Log In
Log In
Log In
Log In
Upgrade
Chronic Therapies Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medication Delivery
-
Log In
Log In
Log In
Log In
Upgrade
Medication Delivery Growth
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Nutrition
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Nutrition Growth
-
Log In
Log In
Log In
Log In
Upgrade
Advanced Surgery
1.10B
Log In
Log In
Log In
Log In
Upgrade
Advanced Surgery Growth
3.84%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Growth
-
Log In
Log In
Log In
Log In
Upgrade
Acute Therapies
-
Log In
Log In
Log In
Log In
Upgrade
Acute Therapies Growth
-
Log In
Log In
Log In
Log In
Upgrade
Patient Support Systems
-
Log In
Log In
Log In
Log In
Upgrade
Patient Support Systems Growth
-
Log In
Log In
Log In
Log In
Upgrade
Surgical Solutions
-
Log In
Log In
Log In
Log In
Upgrade
Surgical Solutions Growth
-
Log In
Log In
Log In
Log In
Upgrade
Front Line Care
1.14B
Log In
Log In
Log In
Log In
Upgrade
Front Line Care Growth
-2.30%
Log In
Log In
Log In
Log In
Upgrade
Injectables and Anesthesia
1.37B
Log In
Log In
Log In
Log In
Upgrade
Injectables and Anesthesia Growth
0.73%
Log In
Log In
Log In
Log In
Upgrade
Drug Compounding
1.04B
Log In
Log In
Log In
Log In
Upgrade
Drug Compounding Growth
10.71%
Log In
Log In
Log In
Log In
Upgrade
Other Revenue (Post-Q2 2023 Reporting)
67.00M
Log In
Log In
Log In
Log In
Upgrade
Other Revenue (Post-Q2 2023 Reporting) Growth
76.71%
Log In
Log In
Log In
Log In
Upgrade
Infusion Therapies
4.10B
Log In
Log In
Log In
Log In
Upgrade
Care & Connectivity Solutions
1.81B
Log In
Log In
Log In
Log In
Upgrade
BioPharma Solutions
-
Log In
Log In
Log In
Log In
Upgrade
BioPharma Solutions Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Revenue (Pre-Q3 2023 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Other Revenue (Pre-Q3 2023 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
-861.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Products & Therapies Operating Income
950.00M
Log In
Log In
Log In
Log In
Upgrade
Medical Products & Therapies Operating Income Growth
-3.49%
Log In
Log In
Log In
Log In
Upgrade
Healthcare Systems & Technologies Operating Income
468.00M
Log In
Log In
Log In
Log In
Upgrade
Healthcare Systems & Technologies Operating Income Growth
12.79%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Operating Income
313.00M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Operating Income Growth
-23.98%
Log In
Log In
Log In
Log In
Upgrade
Kidney Care Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Other Operating Income
18.00M
Log In
Log In
Log In
Log In
Upgrade
Other Operating Income Growth
53.33%
Log In
Log In
Log In
Log In
Upgrade
Other
-861.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
United States
5.85B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.79%
Log In
Log In
Log In
Log In
Upgrade
Emerging Markets
1.35B
Log In
Log In
Log In
Log In
Upgrade
Emerging Markets Growth
-1.08%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
3.44B
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
4.36%
Log In
Log In
Log In
Log In
Upgrade
Americas
-
Log In
Log In
Log In
Log In
Upgrade
Americas Growth
-
Log In
Log In
Log In
Log In
Upgrade
EMEA
-
Log In
Log In
Log In
Log In
Upgrade
EMEA Growth
-
Log In
Log In
Log In
Log In
Upgrade
APAC
-
Log In
Log In
Log In
Log In
Upgrade
APAC Growth
-
Log In
Log In
Log In
Log In
Upgrade
Hillrom
-
Log In
Log In
Log In
Log In
Upgrade
Hillrom Growth
-
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 2011 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2018
Americas Operating Income
Log In
Log In
Log In
Log In
Upgrade
Americas Operating Income Growth
Log In
Log In
Log In
Log In
Upgrade
EMEA Operating Income
Log In
Log In
Log In
Log In
Upgrade
EMEA Operating Income Growth
Log In
Log In
Log In
Log In
Upgrade
APAC Operating Income
Log In
Log In
Log In
Log In
Upgrade
APAC Operating Income Growth
Log In
Log In
Log In
Log In
Upgrade
Hillrom Operating Income
Log In
Log In
Log In
Log In
Upgrade
Hillrom Operating Income Growth
Log In
Log In
Log In
Log In
Upgrade